DORCHESTER WEALTH MANAGEMENT Co Has $2.07 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

DORCHESTER WEALTH MANAGEMENT Co cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 37.6% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 3,534 shares of the healthcare conglomerate’s stock after selling 2,127 shares during the quarter. DORCHESTER WEALTH MANAGEMENT Co’s holdings in UnitedHealth Group were worth $2,066,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of UNH. Wealthcare Advisory Partners LLC boosted its position in UnitedHealth Group by 6.3% during the 1st quarter. Wealthcare Advisory Partners LLC now owns 5,512 shares of the healthcare conglomerate’s stock worth $2,727,000 after acquiring an additional 326 shares during the last quarter. Signet Financial Management LLC raised its stake in shares of UnitedHealth Group by 8.0% during the 1st quarter. Signet Financial Management LLC now owns 725 shares of the healthcare conglomerate’s stock worth $358,000 after purchasing an additional 54 shares in the last quarter. 180 Wealth Advisors LLC raised its stake in shares of UnitedHealth Group by 40.9% during the 1st quarter. 180 Wealth Advisors LLC now owns 1,939 shares of the healthcare conglomerate’s stock worth $959,000 after purchasing an additional 563 shares in the last quarter. Capital Asset Advisory Services LLC raised its stake in shares of UnitedHealth Group by 9.8% during the 1st quarter. Capital Asset Advisory Services LLC now owns 7,125 shares of the healthcare conglomerate’s stock worth $3,247,000 after purchasing an additional 638 shares in the last quarter. Finally, AMF Tjanstepension AB raised its stake in shares of UnitedHealth Group by 113.3% during the 1st quarter. AMF Tjanstepension AB now owns 197,274 shares of the healthcare conglomerate’s stock worth $97,618,000 after purchasing an additional 104,798 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the company. Bank of America dropped their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Cantor Fitzgerald increased their price target on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research note on Wednesday, October 16th. HSBC cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 17th. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday. Finally, Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and increased their price target for the company from $481.00 to $647.00 in a research note on Wednesday, July 17th. Four research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Stock Performance

UNH opened at $560.82 on Friday. The firm has a market cap of $517.87 billion, a P/E ratio of 36.54, a price-to-earnings-growth ratio of 1.67 and a beta of 0.58. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $608.63. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91. The business’s fifty day moving average is $584.16 and its 200-day moving average is $536.49.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group’s quarterly revenue was up 9.2% on a year-over-year basis. During the same period in the prior year, the firm posted $6.56 EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.50%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.